Clinical trials for cardiac patients.

Sharp offers numerous heart-related clinical trials. These trials are vital to finding and advancing heart treatment options and play a key role in saving the lives of more heart patients.

Research improves lives.

We are currently involved in studies covering the following:

• Coronary artery blockage angioplasty and stenting treatment
• Cardiac medications, such as blood thinners or anticoagulants and their reversal agents
• Use of technology for early detection of subclinical atrial fibrillation/atrial tachyarrhythmia and device malfunction on patients with cardiac implantable electronic devices
• Medication alternatives for the prevention of atrial fibrillation-related strokes
• Nonsurgical treatment options for aortic stenosis

Enroll in an active cardiac clinical trial.

If you are interested in participating in a clinical trial, please consult with your physician or contact the Sharp Center for Research at 858-939-7198 or send us an email.

• NCT02389946 - coronary artery disease, atherosclerosis, coronary myocardial ischemia, ischemic heart disease, acute coronary syndrome, angina pectoris; sponsored by Biotronik, Inc., study for Orsiro Sirolimus Eluting Coronary Stent System
• NCT02290028 - heart failure, sponsored by Biotronik, Inc., study drugs Sentus OTW QP L and Sentus OTW QP S

Learn more about cardiac clinical trials.

To learn more about clinical trials at Sharp, visit the Sharp Center for Research or send us an email.